DOACs

Advertisement
Patrick DalyAtrial Fibrillation | September 6, 2023
Researchers compared the safety and efficacy of two direct oral anticoagulants (DOACs), apixaban and rivaroxaban, ...
Patrick DalyAtrial Fibrillation | April 23, 2023
In a study in the European Stroke Journal, researchers compared once-daily direct oral anticoagulant (DOAC) use, ...
Patrick DalyAtrial Fibrillation | May 15, 2023
According to a study, published in Age and Ageing, the association between direct oral anticoagulant (DOAC) use and ...
Patrick DalyAtrial Fibrillation | April 23, 2023
Researchers performed a meta-analysis to assess the safety and efficacy of direct oral anticoagulants (DOAC) for ...
Patrick DalyAtrial Fibrillation | April 23, 2023
In the pilot study, ORIGAMI, researchers investigated whether direct oral anticoagulants (DOACs) could be safely used to ...
DocWire News EditorsAtrial Fibrillation | September 6, 2023
According to a study published in Cardiovascular Intervention and Therapeutics, the safety and efficacy profiles of left ...
Rob DillardVTE | August 30, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug ...
DocWire News EditorsAtrial Fibrillation | April 23, 2023
Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an ...
Najah Khan, MDCardioNerds | August 29, 2023
In patients with a first unprovoked venous thromboembolism (VTE), the long-term risks and consequences of ...
Victoria SochaChronic Kidney Disease | February 5, 2024
The third most common factor associated with cardiovascular death is venous thromboembolism (VTE), including deep vein ...
Rob DillardCardiology | April 23, 2023
Lower Blood Pressure at Hospital Admission Increases the Risk of Heart Failure Death ...
Rebecca AraujoAtrial Fibrillation | April 23, 2023
A new study found that under-dosing of direct oral anticoagulants (DOACs) in patients with extreme obesity and atrial ...
Rob DillardVTE | August 30, 2023
A new study shows that hospitalized patients with SARS-CoV-2 (COVID-19) are more likely to have venous thromboembolism ...
Rob DillardVTE | August 30, 2023
In assessing hemorrhage risk factors for venous thromboembolism (VTE) patients taking direct oral anticoagulants ...
DocWire News EditorsVTE | August 30, 2023
A Scandinavian study suggested that the use of direct oral anticoagulants in patients with venous thromboembolism (VTE) ...
Rebecca AraujoASH Annual Meeting 2020 | August 30, 2023
According to data presented at the 2020 American Society of Hematology Annual Meeting & Exposition, the use of ...
DocWire News EditorsThrombophilia | September 5, 2023
A recent study in the Journal of the American Heart Association suggests that direct oral anticoagulants and ...
Rebecca AraujoDeep Vein Thrombosis | August 30, 2023
A study published in Experimental and Therapeutic Medicine showed direct anti-inflammatory potential of direct oral ...
DocWire News EditorsAHA Scientific Sessions 2020 | April 23, 2023
Patients with chronic kidney disease (CKD) and non-valvular atrial fibrillation (NVAF) were more likely to use vitamin K ...
Rebecca AraujoVTE | September 6, 2023
Direct oral anticoagulants (DOACs) showed promise as alternatives to low molecular weight heparin (LMWH) or vitamin K ...
Advertisement